Evogene Ltd.

ILA 94.30As of Sun 8 Nov 2026, 12:00 UTC
TASE:EVGNHealthcare
Country Israel
PE (Fwd) •••
TSR 10Y CAGR (42.18%)
Div yield —
ROE (182.75%)
Biotechnology
Beta (5Y) 0.67
PE TTM —
TSR TTM (77.52%)
Mkt cap ILS 14.90M
ROIC (77.61%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
ILA 101
6.79%
99.94%
Hold 6|11|4|1|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.01
1.04
1.09
1.17
15.26%
22.21%
27.07%
26.12%
Revenue$M
1.482
1.454
1.447
1.499
12.18%
10.73%
6.44%
6.25%
Peers (US$4.606M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.614
0.895
0.825
EBIT/Intx
0.630
0.263
0.349
Own earn%
37.20
52.65
77.51
Sh yield%
34.73
50.54
52.27
Owners
Insiders/Inst%
3.98
32.73
Short interest%
5.57
SBC / revenue%
5.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
25–37
$1 testx
−0.7
Incr. ROIC%
−1